Clinical characteristics of patients with metastatic castration-resistant prostate cancer after treatment with combined androgen blockade

Table 2 Multivariate linear regression analysis for model prediction

Model	Unstandardised coefficient		Standardised coefficient	t	Significance	95% CI for Β
Model	B	SE	β	t	Significance	Lower bound	Upper bound
(Constant)	22.373	7.874		2.841	0.009	6.122	38.624
Enzalutamide treatment (months)	2.265	0.678	0.596	3.343	0.003	0.867	3.664
Docetaxel treatment (months)	− 0.688	0.523	− 0.231	− 1.314	0.201	− 1.768	0.392
Abiraterone treatment (months)	− 0.344	0.603	− 0.098	− 0.570	0.574	− 1.589	0.901

ISSN: 1471-2490